• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Immuno-Oncology

The AJMC® Immuno-Oncology compendium is a comprehensive resource for clinical news and expert insights for treatments that utilize the body's immune system to fight cancer, such as immune checkpoint inhibitors and chimeric antigen receptor T-cell therapies.

Latest News

Princess Catherine, Duchess of Wales | Image credit: Wikipedia
Preventative Chemotherapy? Not Quite, but Studies Are Underway in Immunoprevention

March 23rd 2024

The Princess of Wales is likely referencing adjuvant chemotherapy, but there is a growing field of immunoprevention, which seeks to target precancerous lesions or block heritable cancers.

Keytruda packaging | Image credit: Merck
Pembrolizumab Plus Olaparib Falls Short in Phase 3 Study When Used First Line in Metastatic, Nonsquamous NSCLC

March 21st 2024

FDA Grants Accelerated Approval to Liso-Cel for CLL/SLL After BTK, BCL-2 Inhibitors
FDA Grants Accelerated Approval to Liso-Cel for CLL/SLL After BTK, BCL-2 Inhibitors

March 15th 2024

Registry Data Inconclusive on Risk of Secondary Primary Malignancy After CAR T, Authors Say
Registry Data Inconclusive on Risk of Secondary Primary Malignancy After CAR T, Authors Say

March 14th 2024

researcher in lab | Image credit: StockPhotoPro - stock.adobe.com
Real-World Study Confirms Nivolumab Plus Ipilimumab Safety in Advanced NSCLC

March 8th 2024

More News

© 2024 MJH Life Sciences
AJMC®
All rights reserved.